Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis (original) (raw)
Hofmann AF (1994) Pharmacology of ursodeoxycholic acid, an enterohepatic drug. Scand J Gastroenterol Suppl204: 1–15 ArticleCASPubMed Google Scholar
Leuschner U et al. (1985) Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study. Dig Dis Sci30: 642–649 ArticleCASPubMed Google Scholar
Poupon R et al. (1987) Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet1: 834–836 ArticleCASPubMed Google Scholar
Paumgartner G and Beuers U (2004) Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis8: 67–81 ArticlePubMed Google Scholar
Lazaridis KN et al. (2001) Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. J Hepatol35: 134–146 ArticleCASPubMed Google Scholar
Poupon R and Poupon RE (2000) Treatment of primary biliary cirrhosis. Baillieres Best Pract Res Clin Gastroenterol14: 615–628 ArticleCASPubMed Google Scholar
Goulis J et al. (1999) Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet354: 1053–1060 ArticleCASPubMed Google Scholar
Gluud C and Christensen E (2002) Ursodeoxycholic acid for primary biliary cirrhosis. The Cochrane Database of Systematic Reviews, Issue 4, Art. No CD000551 Google Scholar
Poupon RE (2000) Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past—issues for the future. J Hepatol32: 685–688 ArticleCASPubMed Google Scholar
Palma J et al. (1997) Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol27: 1022–1028 ArticleCASPubMed Google Scholar
Glantz A et al. (2005) Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology42: 1399–1405 ArticleCASPubMed Google Scholar
Kondrackiene J et al. (2005) Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology129: 894–901 ArticleCASPubMed Google Scholar
Trauner M and Boyer JL (2003) Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev83: 633–671 ArticleCASPubMed Google Scholar
Sauer P et al. (1999) Influence of cholestasis on absorption of ursodeoxycholic acid. Dig Dis Sci44: 817–822 ArticleCASPubMed Google Scholar
Hruz P et al. (2006) Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis. Gut55: 395–402 ArticleCASPubMedPubMed Central Google Scholar
Jazrawi RP et al. (1994) Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. Gastroenterology106: 134–142 ArticleCASPubMed Google Scholar
Medina JF et al. (1997) Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology25: 12–17 ArticleCASPubMed Google Scholar
Fickert P et al. (2001) Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology121: 170–183 ArticleCASPubMed Google Scholar
Marschall HU et al. (2005) Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology129: 476–485 ArticlePubMed Google Scholar
Beuers U et al. (2001) Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology33: 1206–1216 ArticleCASPubMed Google Scholar
Kurz AK et al. (2001) Tauroursodesoxycholate-induced choleresis involves p38 (MAPK) activation and translocation of the bile salt export pump in rats. Gastroenterology121: 407–419 ArticleCASPubMed Google Scholar
Dombrowski F et al. (2006) Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver. Lab Invest86: 166–174 ArticleCASPubMed Google Scholar
Kubitz R et al. (2004) Trafficking of the bile salt export pump from the Golgi to the canalicular membrane is regulated by the p38 MAP kinase. Gastroenterology126: 541–553 ArticleCASPubMed Google Scholar
Crawford JM (1996) Role of vesicle-mediated transport pathways in hepatocellular bile secretion. Semin Liver Dis16: 169–189 ArticleCASPubMed Google Scholar
Kubitz R et al. (2005) Biliary transport systems: short-term regulation. Methods Enzymol400: 542–557 ArticleCASPubMed Google Scholar
Beuers U et al. (1993) Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca2+ mechanisms defective in cholestasis. J Clin Invest92: 2984–2993 ArticleCASPubMedPubMed Central Google Scholar
Beuers U et al. (1993) Effects of tauroursodeoxycholic acid on cytosolic Ca2+ signals in isolated rat hepatocytes. Gastroenterology104: 604–612 ArticleCASPubMed Google Scholar
Bouscarel B et al. (1993) Ursodeoxycholate mobilizes intracellular Ca2+ and activates phosphorylase a in isolated hepatocytes. Am J Physiol264 (Pt 1): G243–G251 CASPubMed Google Scholar
Beuers U et al. (1996) Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. Gastroenterology110: 1553–1563 ArticleCASPubMed Google Scholar
Stravitz RT et al. (1996) Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7 alpha-hydroxylase. Am J Physiol271 (Pt 1): G293–G303 CASPubMed Google Scholar
Bouscarel B et al. (1995) Ursodeoxycholic acid inhibits glucagon-induced cAMP formation in hamster hepatocytes: a role for PKC. Am J Physiol268 (Pt 1): G300–G310 CASPubMed Google Scholar
Bouscarel B et al. (1999) Signal transduction and hepatocellular bile acid transport: cross talk between bile acids and second messengers. Gastroenterology117: 433–452 ArticleCASPubMed Google Scholar
Milkiewicz P et al. (2002) Hepatoprotection with tauroursodeoxycholate and beta muricholate against taurolithocholate induced cholestasis: involvement of signal transduction pathways. Gut51: 113–119 ArticleCASPubMedPubMed Central Google Scholar
Beuers U et al. (1998) Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications. Hepatology28: 1449–1453 ArticleCASPubMed Google Scholar
Kubitz R et al. (2004) Ca2+-dependent protein kinase C isoforms induce cholestasis in rat liver. J Biol Chem279: 10323–10330 ArticleCASPubMed Google Scholar
Beuers U et al. (1999) Modulation of protein kinase C by taurolithocholic acid in isolated rat hepatocytes. Hepatology29: 477–482 ArticleCASPubMed Google Scholar
Beuers U et al. (2003) Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets. J Biol Chem278: 17810–17818 ArticleCASPubMed Google Scholar
Haussinger D et al. (2003) Involvement of integrins and Src in tauroursodeoxycholate-induced and swelling-induced choleresis. Gastroenterology124: 1476–1487 ArticlePubMedCAS Google Scholar
Schliess F et al. (1997) Mitogen-activated protein kinases mediate the stimulation of bile acid secretion by tauroursodeoxycholate in rat liver. Gastroenterology113: 1306–1314 ArticleCASPubMed Google Scholar
Stiehl A et al. (1995) Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment. J Hepatol23: 283–289 CASPubMed Google Scholar
Boyer JL et al. Up-regulation of a basolateral FXR-dependent bile acid efflux transporter, OSTα–OSTβ, in cholestasis in humans and rodents. Am J Physiol Gastrointest Liver Physiol, in press
Noe J et al. (2001) Characterization of the mouse bile salt export pump overexpressed in the baculovirus system. Hepatology33: 1223–1231 ArticleCASPubMed Google Scholar
Reinehr R et al. (2003) Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. Gastroenterology125: 839–853 ArticleCASPubMed Google Scholar
Benz C et al. (1998) Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. J Hepatol28: 99–106 ArticleCASPubMed Google Scholar
Rodrigues C et al. (1998) Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med4: 165–178 ArticleCASPubMedPubMed Central Google Scholar
Benz C et al. (2000) Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes. Eur J Clin Invest30: 203–209 ArticleCASPubMed Google Scholar
Azzaroli F et al. (2002) Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes. Hepatology36: 49–54 ArticleCASPubMed Google Scholar
Graf D et al. (2002) Taurolithocholic acid-3 sulfate induces CD95 trafficking and apoptosis in a c-Jun N-terminal kinase-dependent manner. Gastroenterology122: 1411–1427 ArticleCASPubMed Google Scholar
Schoemaker MH et al. (2004) Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology39: 1563–1573 ArticleCASPubMed Google Scholar
Sola S et al. (2005) Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-β1-induced apoptosis in rat hepatocytes. Hepatology42: 925–934 ArticleCASPubMed Google Scholar
Fickert P et al. (2005) Oncosis represents the main type of cell death in mouse models of cholestasis. J Hepatol42: 378–385 ArticleCASPubMed Google Scholar
Guicciardi ME and Gores GJ (2005) Cholestatic hepatocellular injury: what do we know and how should we proceed? J Hepatol42: 297–300 ArticlePubMed Google Scholar
Paolini M et al. (1999) Bile acid structure and selective modulation of murine hepatic cytochrome P450-linked enzymes. Hepatology30: 730–739 ArticleCASPubMed Google Scholar
Schuetz EG et al. (2001) Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem276: 39411–39418 ArticleCASPubMed Google Scholar
Bodin K et al. (2001) Antiepileptic drugs increase plasma levels of 4β-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. J Biol Chem276: 38685–38689 ArticleCASPubMed Google Scholar
Dilger K et al. (2005) No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis. Hepatology41: 595–602 ArticleCASPubMed Google Scholar
Calmus Y et al. (1990) Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology11: 12–15 ArticleCASPubMed Google Scholar
Tanaka H et al. (1996) Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway. J Immunol156: 1601–1608 CASPubMed Google Scholar
Weitzel C et al. (2005) Ursodeoxycholic acid induced activation of the glucocorticoid receptor in primary rat hepatocytes. Eur J Gastroenterol Hepatol17: 169–177 ArticleCASPubMed Google Scholar
Hofmann AF (1999) Bile acids: the good, the bad, and the ugly. News Physiol Sci14: 24–29 CASPubMed Google Scholar
Fickert P et al. (2004) Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology127: 261–274 ArticleCASPubMed Google Scholar
Heuman DM et al. (1996) Adsorption of mixtures of bile salt taurine conjugates to lecithin-cholesterol membranes: implications for bile salt toxicity and cytoprotection. J Lipid Res37: 562–573 CASPubMed Google Scholar
Lindor KD et al. (1998) Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis. Am J Gastroenterol93: 1498–1504 ArticleCASPubMed Google Scholar
Rost D et al. (2004) Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis. Hepatology40: 693–698 ArticleCASPubMed Google Scholar
Van Nieuwkerk CM et al. (1996) Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology111: 165–171 ArticleCASPubMed Google Scholar
Fickert P et al. (2002) Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology123: 1238–1251 ArticleCASPubMed Google Scholar
Alpini G et al. (2002) Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha. Hepatology35: 1041–1052 ArticleCASPubMed Google Scholar
Dranoff JA et al. (2001) Polarized expression and function of P2Y ATP receptors in rat bile duct epithelia. Am J Physiol Gastrointest Liver Physiol281: G1059–G1067 ArticleCASPubMed Google Scholar
Prieto J et al. (1999) Assessment of biliary bicarbonate secretion in humans by positron emission tomography. Gastroenterology117: 167–172 ArticleCASPubMed Google Scholar
Marteau P et al. (1990) Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man. Hepatology12: 1206–1208 ArticleCASPubMed Google Scholar
Eusufzai S et al. (1991) Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test. Gut32: 1044–1048 ArticleCASPubMedPubMed Central Google Scholar
Stiehl A et al. (1990) Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids. Gastroenterology98: 424–428 ArticleCASPubMed Google Scholar
Lanzini A et al. (2003) Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration. Gut52: 1371–1375 ArticleCASPubMedPubMed Central Google Scholar
Hofmann AF (2003) Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry. Gut52: 1239–1241 ArticleCASPubMedPubMed Central Google Scholar
Beuers U et al. (1992) Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease. Hepatology15: 603–608 ArticleCASPubMed Google Scholar
Rudolph G et al. (1993) Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis. Hepatology17: 1028–1032 ArticleCASPubMed Google Scholar
Yoshikawa M et al. (1992). Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology16: 358–364 ArticleCASPubMed Google Scholar
Calmus Y et al. (1992) Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-alpha production by monocytes. Hepatology16: 719–723 ArticleCASPubMed Google Scholar
Bergamini A et al. (1997) Bile acids with differing hydrophilic–hydrophobic properties do not influence cytokine production by human monocytes and murine Kupffer cells. Hepatology25: 927–933 ArticleCASPubMed Google Scholar
Poo JL et al. (1992) Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat. Gastroenterology102: 1752–1759 ArticleCASPubMed Google Scholar
Corpechot C et al. (2000) The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. Hepatology32: 1196–1199 ArticleCASPubMed Google Scholar
Beuers U et al. (1991) Formation of iso-ursodeoxycholic acid during administration of ursodeoxycholic acid in man. J Hepatol13: 97–103 ArticleCASPubMed Google Scholar
Rust C et al. (2000) The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3- kinase-dependent survival signaling cascade. J Biol Chem275: 20210–20216 ArticleCASPubMed Google Scholar